RIVAROXABAN: AN ORAL DIRECT INHIBITOR OF FACTOR X-A
Journal Title: International Research Journal of Pharmacy (IRJP) - Year 2011, Vol 2, Issue 8
Abstract
Venous thrombo embolism (VTE), which includes deep vein thrombosis and pulmonary embolism, is a major cause of morbidity and mortality in patients undergoing major orthopaedic surgery, and routine thrombo prophylaxis has been the standard of care over the last 20 years. Currently available options for the prevention of venous thrombo embolism in major orthopedic surgery include low-molecular-weight heparins, vitamin K antagonists and, more recently, the synthetic pentasaccharide fondaparinux. Although effective, these drugs have several limitations, and new oral antithrombotics offering predictable, effective and safe anticoagulation are strongly needed. This overview focuses on the most advanced oral direct inhibitors of factor Xa, rivaroxaban. Rivaroxaban, an oral oxazolidinone-based anticoagulant, is a potent, selective direct inhibitor of factor Xa that is used in the prevention of venous thrombo embolism in adult patients after total hip replacement (THR) or total knee replacement (TKR) surgery. In four large, clinical trials, oral rivaroxaban was more effective than subcutaneous enoxaparin in preventing postoperative VTE in patients undergoing total hip replacement or total knee replacement surgery. Notably, the superior efficacy of rivaroxaban was achieved with a low but not significant increase in the incidence of major bleeding episodes. In addition, preliminary pharma co-economic analyses in several countries indicate that rivaroxaban is a cost-effective treatment strategy versus enoxaparin. Although the position of rivaroxaban relative to other therapies remains to be fully determined, it is an effective emerging option for the prevention of venous thrombo embolism following total hip replacement and total knee replacement.
Authors and Affiliations
Hiren Mehta , Paresh Patel , Varsha Galani
Keywords
Related Articles
- EP ID EP103283
- DOI -
- Views 100
- Downloads 0
QSAR MODELING OF GELATINASE INHIBITORS: MLR APPROACH
Matrix metalloproteinases are regulated by growth factors, hormones, cytokines etc. and endogenous inhibitors control them. Over expression of matrix metalloproteinases can lead to a variety of pathological disorders whi...
A REVIEW ON LEMON GRASS: AGRICULTURAL AND MEDICINAL ASPECT
Lemongrass (Cymbopogan flexuosus and Cymbopogan Citraus) is regarded as one of the grass which is commonly available in India and abroad. It is widely used in different conditions of pain and discomfort. The oil (Lemongr...
ENHANCING SOLUBILITY AND DISSOLUTION OF CELECOXIB BY SPRAY DRYING TECHNIQUE
Celecoxib, a selective COX-2 inhibitor, exhibits poor water solubility, dissolution and flow properties. Thus, the aim of the present study was to improve the solubility and dissolution rate of celecoxib by preparing cry...
A NOVEL REVIEW ON ERYTHRINA VARIEGATA
Medicinal plants are nature’s gift to human society to make disease free healthy life. More than thousand medicinal plants are recognised in our country. The present review is therefore an effort to give a detail survey...
ANALYTICAL STUDY OF CURCUMIN CONTENT IN DIFFERENT DOSAGE FORMS CONTAINING TURMERIC EXTRACT POWDER AND TURMERIC OLEORESIN
Different dosage forms namely tablets, capsules, creams and syrups were analysed for curcumin content, by the well-known spectrophotometric method. Turmeric extract powder was used as a source of curcumin in capsule and...